David Fairlie
The University Of Queensland, QLD, Australia
- This delegate is presenting an abstract at this event.

David is Head of Chemistry and Structural Biology at the Institute for Molecular Bioscience, University of Queensland. He was educated at University of Adelaide, Australian National University, University of New South Wales, Stanford University and University of Toronto. He has continuously held ARC and NHMRC Fellowships since 2002 and consulted to and collaborated with numerous pharma companies worldwide. His research at chemistry-biology interfaces has focussed on design of small organic molecules that modulate enzymes, GPCRs, protein-protein interactions, cell signalling pathways, and on elucidating mechanisms of disease development, immune responses and drug action.
Presentations this author is a contributor to:
Europium-labeled synthetic C3a protein as a novel fluorescent probe for human complement C3a receptor (#133)
8:00 PM
Chongyang Wu
Poster Session 1
Development of cyclic-peptide scaffolds to target intracellular protein-protein interactions in cancer cells (#120)
8:00 PM
Gregoire Philippe
Poster Session 1
Peptide Compression For Cell and Oral Bioavailability. (#22)
11:00 AM
David Fairlie
Session 3 - Peptide Chemistry
Enhancing vancomycin potency via complexation with silver ions (#206)
8:00 PM
Zyta M Ziora
Poster Session 2